Literature DB >> 19356440

Correspondence between the 17-segment model and coronary arterial anatomy using contrast-enhanced cardiac magnetic resonance imaging.

José T Ortiz-Pérez1, José Rodríguez, Sheridan N Meyers, Daniel C Lee, Charles Davidson, Edwin Wu.   

Abstract

OBJECTIVES: The purpose of this study was to investigate the correspondence between the coronary arterial anatomy and supplied myocardium based on the proposed American Heart Association 17-segment model.
BACKGROUND: Standardized assignment of coronary arteries to specific myocardial segments is currently based on empirical assumptions.
METHODS: A cardiac magnetic resonance study was performed in 93 subjects following acute myocardial infarction treated with primary percutaneous coronary intervention. Two observers blindly reviewed all angiograms to examine the location of the culprit lesion and coronary dominance. Two additional observers scored for the presence of cardiac magnetic resonance hyperenhancement (HE) on a 17-segment model. Segments were divided based on anatomical landmarks such as the interventricular grooves and papillary muscles.
RESULTS: In a per-segment analysis, 23% of HE segments were discordant with the empirically assigned coronary distribution. Presence of HE in the basal anteroseptal, mid-anterior, mid-anteroseptal, or apical anterior wall was 100% specific for left anterior descending artery occlusion. The left anterior descending artery infarcts frequently involved the mid-anterolateral, apical lateral, and apical inferior walls. No segment was 100% specific for right coronary artery or left circumflex artery (LCX) occlusion, although HE in the basal anterolateral wall was highly specific (98%) for LCX occlusion. Combination of HE in the anterolateral and inferolateral walls was 100% specific for a LCX occlusion, and when extended to the inferior wall, was also 100% specific for a dominant or codominant LCX occlusion.
CONCLUSIONS: Four segments were completely specific for left anterior descending artery occlusion. No segment can be exclusively attributed to the right coronary artery or LCX occlusion. However, analysis of adjacent segments increased the specificity for a given coronary occlusion. These findings bring objective evidence in the appropriate segmentation of coronary arterial perfusion territories and assist accurate assignment of the culprit vessel in various imaging modalities.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19356440     DOI: 10.1016/j.jcmg.2008.01.014

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  42 in total

1.  Macrocyclic contrast agents for magnetic resonance imaging of chronic myocardial infarction: intraindividual comparison of gadobutrol and gadoterate meglumine.

Authors:  Moritz Wagner; Rene Schilling; Patrick Doeblin; Alexander Huppertz; Reny Luhur; Carsten Schwenke; Martin Maurer; Bernd Hamm; Matthias Taupitz; Tahir Durmus
Journal:  Eur Radiol       Date:  2012-07-08       Impact factor: 5.315

2.  Fusion of CT coronary angiography and whole-heart dynamic 3D cardiac MR perfusion: building a framework for comprehensive cardiac imaging.

Authors:  Jochen von Spiczak; Robert Manka; Alexander Gotschy; Sabrina Oebel; Sebastian Kozerke; Sandra Hamada; Hatem Alkadhi
Journal:  Int J Cardiovasc Imaging       Date:  2017-10-28       Impact factor: 2.357

3.  Is contrast-enhanced cardiac magnetic resonance imaging at 3 T superior to 1.5 T for detection of coronary artery disease?

Authors:  Thomas Walcher; Katharina Ikuye; Wolfgang Rottbauer; Jochen Wöhrle; Peter Bernhardt
Journal:  Int J Cardiovasc Imaging       Date:  2012-07-24       Impact factor: 2.357

4.  Angiographic validation of magnetic resonance assessment of myocardium at risk in non-ST-elevation myocardial infarction.

Authors:  Dominik Buckert; Manuela Mariyadas; Thomas Walcher; Volker Rasche; Jochen Wöhrle; Wolfgang Rottbauer; Peter Bernhardt
Journal:  Int J Cardiovasc Imaging       Date:  2013-04-02       Impact factor: 2.357

5.  Quantification of myocardial perfusion reserve at 1.5 and 3.0 Tesla: a comparison to fractional flow reserve.

Authors:  Peter Bernhardt; Thomas Walcher; Wolfgang Rottbauer; Jochen Wöhrle
Journal:  Int J Cardiovasc Imaging       Date:  2012-04-04       Impact factor: 2.357

6.  Myocardial segmentation based on coronary anatomy using coronary computed tomography angiography: Development and validation in a pig model.

Authors:  Mi Sun Chung; Dong Hyun Yang; Young-Hak Kim; Soo-Jin Kang; Joonho Jung; Namkug Kim; Seung-Ho Heo; Seunghee Baek; Joon Beom Seo; Byoung Wook Choi; Joon-Won Kang; Tae-Hwan Lim
Journal:  Eur Radiol       Date:  2017-03-24       Impact factor: 5.315

7.  Optimisation of coronary vascular territorial 3D echocardiographic strain imaging using computed tomography: a feasibility study using image fusion.

Authors:  Martina Chantal de Knegt; A Fuchs; P Weeke; R Møgelvang; C Hassager; K F Kofoed
Journal:  Int J Cardiovasc Imaging       Date:  2016-08-18       Impact factor: 2.357

8.  The culprit lesion and its consequences: combined visualization of the coronary arteries and delayed myocardial enhancement in dual-source CT: a pilot study.

Authors:  Andreas H Mahnken; Philipp Bruners; Ola Friman; Anja Hennemuth
Journal:  Eur Radiol       Date:  2010-06-23       Impact factor: 5.315

9.  T2 and T2 mapping in ex situ porcine myocardium: myocardial intravariability, temporal stability and the effects of complete coronary occlusion.

Authors:  Bridgette Webb; Martin Manninger; Marlene Leoni; Thomas Widek; Martin Dobrovnik; Daniel Scherr; Rudolf Stollberger; Thorsten Schwark
Journal:  Int J Legal Med       Date:  2019-12-18       Impact factor: 2.686

10.  Regional circumferential strain is a biomarker for disease severity in duchenne muscular dystrophy heart disease: a cross-sectional study.

Authors:  Kan N Hor; Narayan Kissoon; Wojciech Mazur; Resmi Gupta; Richard F Ittenbach; Hussein R Al-Khalidi; Linda H Cripe; Subha V Raman; Michael D Puchalski; William M Gottliebson; D Woodrow Benson
Journal:  Pediatr Cardiol       Date:  2014-08-02       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.